Search
for
Sort by
Research 121–150 of 1000+
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- JAK inhibitors in dermatology: The promise of a new drug class
- Janus Kinase inhibitors in dermatology: a review
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- JAK Inhibitors for Treatment of Alopecia Areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor